Table 5 Selected ADEs associated with specific regimens containing the most suspected agent

VCR + DEX + 6-MP + MTX + MTX(IT)

7(12.73)

12(23.08)

3(9.68)

4(14.29)

4(10.0)

VCR + DOXO + L-ASP + DEX + MTX(IT)

5(9.10)

5(9.62)

5(16.13)

2(7.14)

4(10.0)

VCR + DOXO + L-ASP + MTX(IT)

2(3.64)

2(3.85)

2(6.45)

2(7.14)

1(2.50)

VCR + L-ASP + PDN + MTX(IT)

2(3.64)

2(3.85)

2(6.45)

0(0)

2(5.0)

VCR + L-ASP + MTX + MTX(IT)

1(1.82)

1(1.92)

0(0)

1(3.57)

1(2.50)

ETOPO + CYCLO + MTX + MTX(IT)

11.82)

1(1.92)

1(3.22)

1(3.57)

1(2.50)

ABVE

2(3.64)

2(3.85)

1(3.22)

3(10.71)

2(5.0)

ABVE-PC

4(7.27)

4(7.69)

2(6.45)

1(3.57

3(7.50)

ETOPO + CYCLO

2(3.64)

2(3.85)

1(3.22)

2(7.14)

2(5.0)

ETOPO + TIT

1(1.82)

1(1.92)

1(3.22)

0(0)

1(2.50)

DEX + 6-MP + MTX

1(1.82)

1(1.92)

1(3.22)

0(0)

0(0)

VCR + 6-MP + MTX(IT)

1(1.82)

2(3.85)

0(0)

0(0)

1(2.50)

VCR + MTX + MTX(IT)

1(1.82)

1(1.92)

1(3.22)

0(0)

1(2.50)

VAC

0(0)

1(1.92)

0(0)

1(3.57)

1(2.50)

VAD

8(14.55)

2(3.85)

1(3.22)

3(10.71)

5(12.50)

VCD

3(5.45)

2(3.85)

1(3.22)

2(7.14)

2(5.0)

VCR + CYCLO + Ara-C + 6-MP + L-ASP + MTX(IT)

2(3.64)

2(3.85)

1(3.22)

2(7.14)

1(2.50)

VCR + CYCLO + Ara-C + MTX + DEX + MTX(IT)

1(1.82)

1(1.92)

1(3.22)

0(0)

1(2.50)

VCR + CYCLO + MTX + DOXO + DEX + TIT

1(1.82)

1(1.92)

1(3.22)

1(3.57)

1(2.50)

VCR + CYCLO + MTX + TIT

1(1.82)

0(0)

0(0)

0(0)

0(0)

VCR + CARBO + ETOPO

2(3.64)

1(1.92)

0(0)

0(0)

2(5.0)

VCR + CYCLO + PDN

2(3.64)

1(1.92)

2(6.45)

0(0)

1(2.50)

CISP + DOXO

1(1.82)

1(1.92)

1(3.22)

0(0)

0(0)

Ara-C + TIT

2(3.64)

2(3.85)

2(6.45)

2(7.14)

2(5.0)

Ara-C + DAUN

1(1.82)

1(1.92)

1(3.22)

1(3.57)

1(2.50)

VINBLASTINE

1(1.82)

1(1.92)

0(0)

0(0)

0(0)

TOTAL

55(100)

52(100)

31(100)

28(100)

40(100)